The best of R&D cannot be constrained by national boundaries; R&D is about harnessing expertise from around the world. Our global R&D organisation is well placed to do just that.
AstraZeneca and MedImmune have an R&D presence in nine countries across three continents, covering both small molecules and biologics.
We have a strong and growing R&D presence in Asia. Work at our Bangalore research facility in India is dedicated to finding a new therapy for infectious diseases. At our Innovation Center China in Shanghai, our initial therapeutic focus is on cancer.
We also work with partners from across the world, representing the breadth of organisations; from large and small companies to medical institutions, Governments and charities.
Our R&D sites
Small molecules
UK : Alderley Park and Macclesfield
Sweden : Mölndal
US : Boston MA and Wilmington DE
India : Bangalore
China : Shanghai
Japan : Osaka (Clinical development)
Poland : Warsaw (Clinical development)
Russia : St. Petersburg (Virtual center)
Biologics and vaccines
US : Gaithersburg MD and Mountain View CA
UK : Cambridge